Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TO0E
|
||||
Former ID |
DNC014085
|
||||
Drug Name |
SN-28
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531165] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H24N2O
|
||||
Canonical SMILES |
CN1CCC23CC4=NC5=CC=CC=C5C=C4CC2C1CC6=C3C=C(C=C6)O
|
||||
InChI |
1S/C24H24N2O/c1-26-9-8-24-14-22-17(10-16-4-2-3-5-21(16)25-22)11-20(24)23(26)12-15-6-7-18(27)13-19(15)24/h2-7,10,13,20,23,27H,8-9,11-12,14H2,1H3
|
||||
InChIKey |
HDRKKGULQPRYBL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [531165] | |
Delta-type opioid receptor | Target Info | Inhibitor | [531165] | ||
Kappa-type opioid receptor | Target Info | Inhibitor | [531165] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.